Ignite Creation Date:
2024-05-06 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05254847
Status:
RECRUITING
Last Update Posted:
2022-04-04
First Post:
2022-02-15
Brief Title:
Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC
Sponsor:
Fudan University
Organization:
Fudan University
Organization Data
Organization:
Fudan University
Class:
OTHER
Study ID:
BTC-CaLenT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fudan University
Lead Sponsor Class:
OTHER
Responsible Party:
Lu Wang MD PhD
Responsible Party Title:
Head of liver surgery department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Fudan University
Old Name:
None
Old Organization:
None